Galen Closes Majority Recapitalization of CDx Diagnostics

New York – July 27, 2017 – Cooley advised Galen Partners on completing a majority recapitalization of CDx Diagnostics, a specialized anatomic pathology laboratory. Debt financing was provided by White Oak Finance. Financial terms have not been disclosed.

“We are excited to back CDx’s proprietary computer-assisted cancer detection platform, and CDx is a perfect fit for Galen’s strategy of investing in companies that create value in healthcare,” said David Jahns, managing director of Galen Partners, in a news release.

CDx uses proprietary technology, including advanced neural-network analysis and deep artificial intelligence tools, to enhance the detection of precancerous and cancerous tissue initially for clinical use in the esophagus and oral cavity.

Galen partners, founded in 1999, is a leading healthcare-focused growth equity investment firm. With nearly $1 billion invested over five funds, Galen has helped build more than 70 companies since its inception.

The Cooley corporate team advising Galen included Ron Hopkinson, David Silverman, Brendan Koeth and Gloria Henderson. In addition, Patrick Flanagan, Sean Cornely and Frank Oliver advised on debt financing; Jeremy Naylor and Chris Mayer on tax; Phil Mitchell and Amy Westergen on healthcare; and Brian Hopkins on IP.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.